Disappointments in treating acute leukemia in the elderly

Editorial

T J Hamblin. N Engl J Med. 1995.

. 1995 Jun 22;332(25):1712-3.

doi: 10.1056/NEJM199506223322511.

No abstract available

Comment on

A controlled study of recombinant human granulocyte colony-stimulating factor in elderly patients after treatment for acute myelogenous leukemia. AML Cooperative Study Group.
Dombret H, Chastang C, Fenaux P, Reiffers J, Bordessoule D, Bouabdallah R, Mandelli F, Ferrant A, Auzanneau G, Tilly H, et al. Dombret H, et al. N Engl J Med. 1995 Jun 22;332(25):1678-83. doi: 10.1056/NEJM199506223322504. N Engl J Med. 1995. PMID: 7539109 Clinical Trial.
Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. Cancer and Leukemia Group B.
Stone RM, Berg DT, George SL, Dodge RK, Paciucci PA, Schulman P, Lee EJ, Moore JO, Powell BL, Schiffer CA. Stone RM, et al. N Engl J Med. 1995 Jun 22;332(25):1671-7. doi: 10.1056/NEJM199506223322503. N Engl J Med. 1995. PMID: 7760868 Clinical Trial.